Page 297 - Read Online
P. 297

Ghosh et al. Neuroimmunol Neuroinflammation 2018;5:38  I  http://dx.doi.org/10.20517/2347-8659.2018.28              Page 7 of 11


               Table 6. Comparison of the baseline characteristics and biomarker levels at admission for patients developing hemorrhage
               (hge.) post thrombolysis
                Characteristics       Patients with hge. complications (n = 3)  Patients without hge. complications (n = 7)  P value
                       2
                BMI (kg/m )                     26.5 (1.1)                 26.8 (0.9)               0.66
                Mean age (SD)                   64 (10.8)                  63 (8.2)                 1.0
                Vascular risk factors
                  Hypertension                  3                          4                        0.475
                  Hypercholesterolemia          3                          4                        0.475
                  Diabetes                      2                          3                        1.0
                  AF                            1                          2                        1.0
                CHADS2 score
                  ≥ 2                           1                          3                        1.0
                Bamford classification
                  TACS                          2                          2                        0.5
                  PACS                          0                          3                        0.475
                  PCS                           1                          2                        1.0
                MABP at admission               110.5 (4.2)                118.8 (4.8)              0.032
                CBG at admission                251.4 (109.4)              143.2 (45.7)             0.048
                Mean NIHSS at admission (SD)    10.4 (5.8)                 20.2 (4.0)               0.0137
                CRP (mg/L)                      5.88 (0.24)                5.64 (0.32)              0.28
                Fibrinogen (mg/dL)              478.5 (20.85)              421.4 (26.4)             0.01
                D-dimer (µg/mL)                 6.88 (1.4)                 6.38 (1.7)               0.5
                NSE (ng/mL)                     42.1 (11.2)                30.8 (4.8)               0.07
               Table 6 demonstrated that higher MABP, CBG, and fibrinogen levels at admission predicted significantly higher chance to develop post-
               thrombolysis hemorrhagic complications. Other three biomarkers were not significant predictors of hemorrhagic complications. (N.B-
               in Tables 1, 2, 3, and 6 some patients had multiple comorbidities). BMI: body mass index; TACS: total anterior circulation stroke; PACS:
               partial anterior circulation stroke; PCS: posterior circulation stroke; MABP: mean arterial blood pressure; CBG: capillary blood glucose;
               CRP: C-reactive protein; NSE: neuron specific enolase.

               which develop and compensate for acute arterial occlusion in patients with gradual occlusion of arteries,
               such as in atherosclerosis of cervical or cerebral arteries . Steger et al.  reported that for AF patients with
                                                              [18]
                                                                           [19]
               ischemic stroke, the in-hospital mortality was higher (25% vs. 14%, P < 0.0004) and neurological outcome
               was poorer (65 vs. 90 Barthel index, P < 0.0004). But in our study, multivariate analysis did not establish
               AF as an independent predictor of mortality. AF was non-significantly more frequent among patients with
               severe stroke, unfavorable outcome, and among those who expired. Ntaios et al.  reported that compared
                                                                                   [20]
               with CHADS2 score 0, patients with CHADS2 score 1 and CHADS2 score > 1 had higher risks of ischemic
               stroke [hazard ratio 2.38 (95% CI: 1.41-4.00) and 2.72 (95% CI: 1.68-4.40), respectively] and death [hazard
               ratio 3.58; (95% CI: 1.80-7.12), and 5.45 (95% CI: 2.86-10.40) respectively]. In our study, CHADS2 score ≥
               2 significantly predicted stroke severity but did not predict mortality. Di Tullio et al.  in their “Reduced
                                                                                        [21]
               Ejection Fraction Trial”, demonstrated that baseline left ventricular EF < 15% was inversely and linearly
               associated with the primary outcome, and mortality. Even in warfarin-treated patients, each 5% EF decre-
               ment significantly increased the stroke risk [adjusted hazard ratio 2.125 (95% CI: 1.182-3.818)]. In our study,
               EF < 35% [mean (SD) EF = 26.8 (5.8)] significantly predicted unfavorable outcome and mortality. Although
                             [22]
                                               [23]
               Nedeltchev et al.  and Musolino et al.  reported current smoking, followed by hypercholesterolemia, family
               history of cerebrovascular disease, and hypertension to be the most prevalent risk factors among young isch-
               emic stroke patients, these factors were non-significant predictors of stroke severity and outcome in our study.
                          [24]
               Osmani et al.  reported that TACS had the worst outcome with the highest number of mortalities (72.2%).
               The LS had a better outcome, i.e. 65.7% of the patients were functionally independent by the end of 6 months
               compared to 15% of TACS patients . In our study, patients with TACS had a significantly higher incidence
                                            [24]
                                                                                           [25]
               of severe stroke (57.14%), unfavorable outcome (100%) and mortality (57.14%). Huang et al.  also described
               that TACS was associated with a poor functional outcome, but patients had a better outcome with LS. Medi-
               cations use like statins, anticoagulants and antihypertensives did not affect stroke prognosis, similar to
                                       [26]
                          [7]
               Corso’s study . Koton et al.  described that systolic blood pressure (SBP) at admission was associated with
               stroke severity and disability at discharge or in-hospital death with an adjusted OR of 1.06 (95% CI: 1.04-1.08)
   292   293   294   295   296   297   298   299   300   301   302